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Regional solitary plasmacytoma of the costa is a rare disease and is characterized by only one or two isolated bone
lesions. We report the case of a solitary plasmacytoma of the bone of the right chest wall in an adult. The patient
underwent complete enbloc resection of the chest wall including ribs, muscle and parietal pleura. The patient is
asymptomatic without any recurrence after two months of follow-up.
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Primary malignant tumors of the bony chest wall are rare
and localized solitary plasmacytoma of bone (SPB), char-
acterized by only one or two isolated bone lesions with no
evidence of disease dissemination, is a rare disease that ac-
counts for about 5% of malignant plasma cell tumors [1].
We report the case of SPB in the right chest wall.Case presentation
A 54-year-old the Han Nationality male was admitted to
our hospital presenting with continuous pain in the right
chest for the past 3 months. The pain was sudden in on-
set, non-radiating and increased on coughing. He was a
nonsmoker and had no exposure to any known toxic en-
vironmental fumes or dusts.
A physical examination showed an elliptical swelling on
the right side of the chest over the third rib, about 3 × 4
cm in size, firm and tender. His chest X-ray showed a pul-
monary opacity with well-defined medial and lateral mar-
gins merging with chest wall on right side (Figure 1B). A
computed tomography scan (CT) revealed a well-defined
hypodense soft tissue mass, about 3.2 × 4.1 cm in size, on
right side of the chest wall with invasion into the third rib
(Figure 1A). An additional bone scan found an abnormal
increase in the uptake of radioisotope in the third and
fourth ribs (Figure 2A,B). Upon performing abone marrow* Correspondence: cheguowei_hx@aliyun.com
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lysis for Bence Jones proteins was negative.
As diagnosis was not established through imaging, sur-
gery was scheduled. Under general anesthesia with se-
lective intubation, the patient was subjected to the right
posterolateral thoracotomy through the fourth intercostal
space which revealed a well-restricted tumor of 4.5 × 5 cm
in size arising from the third and fourth ribs anteriorly
(Figure 3A, B). Enbloc resection of third and fourth ribs,
along with the parietal pleura and muscles, was performed
with a 5 cm tumor margin and primary closure was done.
Microscopically, the lesion was composed of many plasma
cells as a thick sheet with scant intercellular stroma. The
plasma cells had extensive basophilic cytoplasms, round
eccentric nuclei with a cartwheel appearance and peri-
nuclear halos (Figure 3C, D). Immunohistochemical stain-
ing revealed that the plasma cells were negative for CD20,
cyclin D1, Igκ, IgG and IgM. The plasma cells were posi-
tive for D138, PC, mum1 and Igλ. The positive rate of
Ki67 was 60%. The histology and immunohistochemical
staining results supported the diagnosis of plasmacytoma.
There was no serum evidence of M-protein. The pa-
tient was doing well without evidence of tumor recur-
rence or secondary neoplasms at two months following
his initial diagnosis.Discussion
Plasmacytoma involving the chest wall is a rare pri-
mary tumor [2] classified as multiple myeloma (MM),
solitary plasmacytoma, extramedullary plasmacytoma
or plasma cell leukemia. More than 95% of thesed. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Chest X-ray and CT showed a mass on the right side
of the chest wall. A and B: Chest X-ray and contrast-enhanced CT
revealed a well-defined soft tissue mass (arrowhead) on right side
abutting the chest wall, with invasion into the third rib.
Figure 2 Bone scan of the patient. Abnormally increased uptake
of radioisotope in the right third and fourth ribs in a bone scan.
A: anterior to posterior view. B: posterior to anterior view. Arrows
indicate the tumor.
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usually shows destruction of the bone cortex with ex-
tension into the surrounding soft tissues. Plasmacy-
toma may be primary or secondary to the disseminated
multiple myeloma and may arise from the osseous or
non-osseous sites.
The ratio of male to female patientsis approximately
1.3:1 and the average age on presentation is 59.5 yearswith a range from 39 to 77 years [3]. The most common
symptoms are pain and spinal nerve compression. In our
case, the patient (who was a 54-year-old male) had a
symptom of constant pain in the chest on the right side
with exacerbation upon coughing. With regard to radio-
logical evaluation, chest radiographs are the most com-
monly performed imaging analysis to evaluate lumps,
but may not always provide a conclusive diagnosis. In
such cases, a spiral CT is the next tool of choice. Plas-
macytoma is typically seen on a CT scan as well-defined,
‘punched-out’ lytic lesions with associated extrapleural soft
tissue mass. In advanced plasmacytoma, there is often
marked erosion, expansion and destruction of bone cor-
tex, sometimes with thick ridging around the periphery,
creating a ‘soap bubble’ appearance [4]. There is also a
word in our case. The patient’schest X-ray with lateral
projection clearly showed a pulmonary lump and his
contrast-enhanced CT revealed a well-defined hypodense
soft tissue mass on the right side of the chest wall with in-
vasion into the third rib. The differential diagnosis of cos-
tal plasmacytoma includes chondrosarcoma, lymphoma,
metastases, osteosarcoma, fibrosarcoma, histiocytoma,
chondroma, lipoma and bone infarction [5].
Figure 3 Macroscopic view of the specimen and histological features. A and B: Macroscopic view of the third and fourth excised ribs with
the tumor. C and D: Histological examination showed many neoplastic plasma cells with the tumor. (hemotoxin and eyolin, ×400 magnification).
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transformation into MM and recurrence. In the past, ra-
diation therapy was used as the primary treatment for
SPB because this tumor is sensitive to radiotherapy. Al-
though there is no established relationship between dos-
age and response; 40 to 50 Gy radiation in 20 to 25
fractions has usually been recommended [6]. Mendenhall
et al. reported a 6% local failure rate in patients with soli-
tary plasmacytoma treated with doses of 40 Gy or
above, in contrast to a 31% failure rate for doses below
40 Gy [7]. Aviles et al. discerned that most patients
treated with adequate radiation therapy alone will de-
velop MM within the first three years after diagnosis
and treatment [8]. When performing surgical resec-
tion, the possibility of structural instability and nerve
injury should be considered for spinal lesions. For
other lesions, variable surgical strategies can be applied
according to the tumor size, extent, patient’s general
condition or surgeon’s experience [6]. One group re-
ported that the primary methods for treating solitary
plasmacytoma were surgery plus radiation therapy in
95 cases and surgery alone in 15 cases. They showed
the lowest incidence of progressive diseases in patients
with solitary plasmacytoma who were treated with sur-
gery plus an adequate dose of radiation therapy [9]. In
our case, we had referred the patient firstly for a wide
excision of a solitary rib tumor containing normal tis-
sue without preoperative confirmation of diagnosis.
The histopathologic diagnosis of SPB was confirmed,and a treatment plan with doses of 40 Gy radiation in
25 fractions was planned for protection against tumor
recurrence.
Conclusions
In conclusion, there are very few reports in the literature
depicting the natural history of SPB in an adult in regard
to its presentation, pathology and treatment [10]. Our
case may help recognition of this rare disease in the
thoracic surgery field, thus avoiding misdiagnosis and in-
adequate treatment.
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